RHODES JASON P sold 99.6% of their position (777.45K shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.86M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−253.04K
Price / share
$22.79
Trade value
$5.77M
% of position
Common Stock
Shares
−127.18K
Price / share
$22.79
Trade value
$2.90M
% of position
Common Stock
Shares
−100.02K
Price / share
$22.79
Trade value
$2.28M
% of position
Common Stock
Shares
−124.38K
Price / share
$23.17
Trade value
$2.88M
% of position
Common Stock
Shares
−29.59K
Price / share
$23.62
Trade value
$698.84K
% of position
Common Stock
Shares
−62.54K
Price / share
$23.17
Trade value
$1.45M
% of position
Common Stock
Shares
−14.84K
Price / share
$23.62
Trade value
$350.62K
% of position
Common Stock
Shares
−49.19K
Price / share
$23.17
Trade value
$1.14M
% of position
Common Stock
Shares
−11.66K
Price / share
$23.62
Trade value
$275.53K
% of position
Common Stock
Shares
−5K
Price / share
$23.61
Trade value
$118.05K
% of position
Net shares
−777.45K
Net value
-$17.86M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/6/2026 | S · Sale | −253.04K | $22.79 | $5.77M | 5.7% | 4.48M | 4.22M |
| Common Stock Indirect | 7/6/2026 | S · Sale | −127.18K | $22.79 | $2.90M | 9.5% | 1.34M | 1.22M |
| Common Stock Indirect | 7/6/2026 | S · Sale | −100.02K | $22.79 | $2.28M | 10.2% | 975.93K | 875.91K |
| Common Stock Indirect | 7/7/2026 | S · Sale | −124.38K | $23.17 | $2.88M | 2.9% | 4.22M | 4.10M |
| Common Stock Indirect | 7/7/2026 | S · Sale | −29.59K | $23.62 | $698.84K | 0.7% | 4.10M | 4.07M |
| Common Stock Indirect | 7/7/2026 | S · Sale | −62.54K | $23.17 | $1.45M | 5.1% | 1.22M | 1.15M |
| Common Stock Indirect | 7/7/2026 | S · Sale | −14.84K | $23.62 | $350.62K | 1.3% | 1.15M | 1.14M |
| Common Stock Indirect | 7/7/2026 | S · Sale | −49.19K | $23.17 | $1.14M | 5.6% | 875.91K | 826.72K |
| Common Stock Indirect | 7/7/2026 | S · Sale | −11.66K | $23.62 | $275.53K | 1.4% | 826.72K | 815.05K |
| Common Stock Indirect | 7/7/2026 | S · Sale | −5K | $23.61 | $118.05K | 62.8% | 7.96K | 2.96K |
| Total | −777.45K | -$17.86M | ||||||